XML 36 R6.htm IDEA: XBRL DOCUMENT v3.20.1
CONSOLIDATED STATEMENT OF EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional paid-in Capital
Retained earnings
Accumulated other comprehensive income (loss)
Treasury Stock
Balance, beginning of the period (in shares) at Mar. 31, 2017   132,875,373       (54,582,392)
Balance, beginning of the period at Mar. 31, 2017 $ 738,980 $ 13,288 $ 1,154,429 $ 602,609 $ 7,999 $ (1,039,345)
Increase (Decrease) in Stockholders' Equity            
Employee stock awards, benefit plans and other issuances (in shares)   1,054,754       (420,419)
Employee stock awards, benefit plans and other issuances 8,665 $ 105 19,622     $ (11,062)
Non-cash stock-based compensation (in shares)   628,208        
Non-cash stock-based compensation 61,460 $ 63 61,397      
Restricted stock units vested (in shares)   1,521,341        
Restricted stock units vested 0 $ 153 (153)      
Acquisition of treasury stock (in shares)           (3,302,106)
Acquisition of treasury stock (88,884)         $ (88,884)
Other comprehensive income (loss):            
Foreign currency translation 2,768       2,768  
Net earnings (loss) 23,480     23,480    
Balance, end of the period (in shares) at Mar. 31, 2018   136,079,676       (58,304,917)
Balance, end of the period at Mar. 31, 2018 749,095 $ 13,609 1,235,679 628,331 10,767 $ (1,139,291)
Increase (Decrease) in Stockholders' Equity            
Employee stock awards, benefit plans and other issuances (in shares)   1,330,757       (1,202,243)
Employee stock awards, benefit plans and other issuances (30,101) $ 133 20,286     $ (50,520)
Non-cash stock-based compensation (in shares)   415,706        
Non-cash stock-based compensation 88,483 $ 41 88,442      
Restricted stock units vested (in shares)   4,039,749        
Restricted stock units vested 0 $ 404 (404)      
Acquisition of treasury stock (in shares)           (2,428,265)
Acquisition of treasury stock (74,421)         $ (74,421)
Non-cash stock-based compensation from discontinued operations 62,861   62,861      
Other comprehensive income (loss):            
Foreign currency translation (2,966)       (2,966)  
Net earnings (loss) 1,028,547     1,028,547    
Warrant exercises 0   (51)     $ 51
Warrant exercises (in shares)           3,488
Acquisition of treasury stock from tender offer (in shares)           11,235,955
Tender offer (503,393)         $ (503,393)
Balance, end of the period (in shares) at Mar. 31, 2019   141,865,888       (73,167,892)
Balance, end of the period at Mar. 31, 2019 1,330,832 $ 14,187 1,406,813 1,669,605 7,801 $ (1,767,574)
Increase (Decrease) in Stockholders' Equity            
Employee stock awards, benefit plans and other issuances (in shares)   266,011       (537,694)
Employee stock awards, benefit plans and other issuances (19,786) $ 27 4,709     $ (24,522)
Non-cash stock-based compensation (in shares)   71,211        
Non-cash stock-based compensation 65,219 $ 7 65,212      
Restricted stock units vested (in shares)   1,342,337        
Restricted stock units vested 0 $ 134 (134)      
Acquisition of treasury stock (in shares)           (4,375,728)
Acquisition of treasury stock (182,190)         $ (182,190)
Other comprehensive income (loss):            
Foreign currency translation (2,056)       (2,056)  
Net earnings (loss) (124,511)     (124,511)    
Liability-classified restricted stock units vested (in shares)   393,306        
Liability-classified restricted stock units vested 17,704 $ 39 17,665      
Acquisition-related replacement stock options 2,300   2,300      
Balance, end of the period (in shares) at Mar. 31, 2020   143,938,753       (78,081,314)
Balance, end of the period at Mar. 31, 2020 $ 1,087,512 $ 14,394 $ 1,496,565 $ 1,545,094 $ 5,745 $ (1,974,286)